Interferon type I Germinal center Chronicity Germinal centers Immune response Myasthenia gravis Interferon IFN COVID-19 Myoblasts Myasthenia Gravis Long-term follow-up Animal models Glucocorticoids Immunology and Microbiology Section FMR1 Myasthénie grave Complete Freund's adjuvant Immunotherapy Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Immunity Clinical cell transplantation Etiology Exercise Human myoblasts Lamin A/C nuclei Cellules th17 Cell-cell communication Follicular hyperplasia Inflammation Autoimmune diseases DICER Thymoma Interferon-β Acetylcholine receptors Interferonopathy Assay comparison Acetylcholine receptor Th17 cells Neuromuscular junction Inflammatory cytokines Immune regulation Adaptive immunity Experimental models Age Gender Chemokines Ectopic germinal centers Heart failure Interleukin 23 Cytokines Experimental mouse models AChR antibodies Autoimmune disease Endogenous nucleic acids Experimental autoimmune myasthenia gravis EAMG Chronic inflammation COX2 Chemokine Anticorps monoclonal Genetics Myasthenia Gravis MG Acetylcholine receptor antibodies Interféron de type I Interferon type-I Il-23 B cells CTCF M3243AG Genetic associations CCL21 Interferon Gd T cells Thymectomy BAFF Thymic epithelial cells Puberty Interleukine-23 Centres germinatifs ectopiques Early-onset myasthenia gravis Interferon de type I LMNA Conduction disease Auto-immunité CD31 Experimental autoimmune myasthenia gravis Thymus Transcriptome Cardiomyopathy Disease susceptibility Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration PBMC Acides nucléiques endogènes Autoimmunity Quality of life Fragile X syndromes Ferrites Antimir-150 MG patients Innate immunity CXCL13-CXCR5